The 5-year analysis of Sun Pharma Advanced Research Company Ltd's performance infers:
Sun Pharma Advanced Research Company Ltd earnings have grown by 0%, whereas share price has depreciated -10.8% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.